Epstein David M. 4
4 · Black Diamond Therapeutics, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4
Epstein David M.
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-02-13+420,000→ 420,000 totalExercise: $2.92Exp: 2033-02-12→ Common Stock (420,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 13, 2024, with the remainder vesting in 36 equal monthly installments thereafter.